Interleukin-18 activates skeletal muscle AMPK and reduces weight gain and insulin resistance in mice


Autoria(s): Lindegaard, Birgitte; Matthews, Vance B.; Brandt, Claus; Hojman, Pernille; Allen, Tamara L.; Estevez, Emma; Watt, Matthew J.; Bruce, Clinton R.; Mortensen, Ole H.; Syberg, Susanne; Rudnicka, Caroline; Abildgaard, Julie; Pilegaard, Henriette; Hidalgo, Juan; Ditlevsen, Susanne; Alsted, Thomas J.; Madsen, Andreas N.; Pedersen, Bente K.; Febbraio, Mark A.
Data(s)

01/09/2013

Identificador

http://hdl.handle.net/10536/DRO/DU:30062067

Idioma(s)

eng

Publicador

American Diabetes Association

Relação

http://dro.deakin.edu.au/eserv/DU:30062067/bruce-interleukin18activates-2013.pdf

http://doi.org/10.2337/db12-1095

Palavras-Chave #interleukin (IL)-18 #obesity #hypophagia #high-fat diet (HFD)-induced insulin resistance #AMP-activated protein kinase (AMPK) #weight gain #skeletal muscle #metabolic homeostasis
Tipo

Journal Article